PMID: 9643528Jun 27, 1998Paper

Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment

Medical Oncology
Y CohenB Modan

Abstract

The relationship between mental diseases and cancer development has been examined in a number of studies but the findings are still inconclusive and suffer from methodological problems. Studies conducted to examine the effect of lithium on malignant cells yielded inconsistent results. The study group included 609 patients treated by lithium carbonate and 2396 controls. A lower but non significant risk (RR = 0.79; CI = 0.17-3.60) to develop non-epithelial tumors was found among lithium carbonate treated psychiatric patients as compared to controls. A significantly (P = 0.05) inverse trend of cancer with lithium dose was observed. The risk of cancer development among each group of psychiatric patients was significantly lower than in the general population (RR = 0.68 for the lithium treated group versus 0.78 for controls). Mental patients have a lower cancer prevalence than the general population and lithium may have a protective effect.

References

Jun 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C Hori, T Oka
Jul 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M TaubG Sato
Oct 25, 1979·The New England Journal of Medicine·J Lieb
Aug 25, 1977·The New England Journal of Medicine·R S SteinH G Jume'an
Aug 25, 1977·The New England Journal of Medicine·R CataneG P Murphy
Jan 1, 1976·International Pharmacopsychiatry·P Plenge
Mar 12, 1990·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·J M SlackG D Paterno
Nov 1, 1989·Journal of Leukocyte Biology·E S KleinermanL A Zwelling
Mar 1, 1989·Journal of Epidemiology and Community Health·P B Mortensen
Mar 1, 1989·Acta Psychiatrica Scandinavica·N ZilberY Lerner
Feb 1, 1988·Journal of Behavioral Medicine·G A Kaplan, P Reynolds
Jan 1, 1986·International Journal of Psychiatry in Medicine·D W Black, G Winokur
Sep 1, 1985·Acta Psychiatrica Scandinavica·J B WoodB J Hagan
Apr 18, 1970·Lancet·T Dousa, O Hechter
Jan 31, 1980·The New England Journal of Medicine·G H LymanD Preston
Jan 1, 1981·Biochemical Pharmacology·C GuerriS Grisolía
Jul 1, 1982·British Journal of Haematology·C E Gauwerky, D W Golde
Mar 1, 1982·Clinical Immunology and Immunopathology·A P WeetmanR Hall
Jan 1, 1980·Acta Haematologica·J L Nielsen
Apr 1, 1980·Journal of Cellular Physiology·K PtashneS Conlon
May 1, 1981·Clinical Immunology and Immunopathology·J BrayF Dusel
Jul 1, 1981·Comprehensive Psychiatry·T J Craig, S P Lin
Apr 1, 1981·Psychosomatic Medicine·R B ShekelleO Paul

❮ Previous
Next ❯

Citations

Sep 1, 2006·Neurochemical Research·Richard S JopeEléonore Beurel
May 7, 2013·Biochemical Pharmacology·Fumi Takahashi-Yanaga
May 29, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Todd D GouldHusseini K Manji
Jan 30, 2013·Cell Research·Shigeo MasudaJuan Carlos Izpisua Belmonte
Oct 31, 2009·Nature Reviews. Drug Discovery·Laura K ChicoD Martin Watterson
May 4, 2006·The Journal of Clinical Investigation·Venkatesh KrishnanOrmond A Macdougald
Sep 6, 2007·PloS One·Fumitaka KugimiyaUng-il Chung
Oct 14, 2009·PloS One·Serdar KorurMaria Maddalena Lino
Mar 25, 2006·Future Oncology·Andrei V Ougolkov, Daniel D Billadeau
Feb 5, 2013·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Yan LanZi-Chun Hua
Nov 2, 2015·Digestive Diseases and Sciences·Mark R Frey
Jun 19, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·R J AtkinsC M Hovens
Apr 15, 2008·Drug Discovery Today·Lisa A Catapano, Husseini K Manji
Feb 16, 2008·Biochemical and Biophysical Research Communications·Mikayo AragakiMamoru Watanabe
Nov 4, 2015·Advanced Drug Delivery Reviews·Ryohichi Sugimura
Jul 27, 2005·Biochemical and Biophysical Research Communications·Abbas ShakooriToshinari Minamoto
May 19, 2006·Expert Opinion on Therapeutic Targets·Sheelagh Frame, Daniella Zheleva
May 19, 2006·Expert Opinion on Therapeutic Targets·Todd D Gould
Apr 24, 2015·Calcified Tissue International·Xuemei WangJing Hu
Mar 26, 2011·The American Journal of Pathology·Paola de CandiaLilia Alberghina
Nov 3, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Ru-Yu HuangYi-Hsin Yang
Jun 3, 2004·Nature Reviews. Drug Discovery·Philip Cohen, Michel Goedert
Nov 12, 2017·The Journal of Membrane Biology·Eric JakobssonLaura Pritchet
Apr 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Todd D Gould, Husseini K Manji
Mar 17, 2010·Surgical Endoscopy·Christian OttoScott Dulchavsky
Jul 16, 2010·Journal of Advanced Nursing·Vari DrennanAmanda Wells
Jul 26, 2002·Oncogene·Øystein FlugeJohan R Lillehaug

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved